Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial
- Resource Type
- Article
- Source
- The Lancet Respiratory Medicine; July 2017, Vol. 5 Issue: 7 p557-567, 11p
- Subject
- Language
- ISSN
- 22132600; 22132619